Indranil Dey serves as Executive at Bluejay Diagnostics, Inc., where they oversee executive responsibilities. Since joining the company, Indranil Dey has executed 7 insider transactions totaling $6.0K, demonstrating a bullish approach to their equity position. Their most recent transaction on Dec 13, 2023 involved purchasing 500 shares valued at $1.6K.
Indranil Dey currently holds 28,526 shares of Bluejay Diagnostics, Inc. (BJDX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Indranil Dey has been a net buyer of BJDX stock. They have purchased $6.0K and sold $0 worth of shares.
Indranil Dey's most recent insider trade was on Dec 13, 2023, when they purchased 500 shares at $3.27 per share.
Get notified when new Form 4 filings are submitted
| $0.44 |
| Discretionary |
| Mar 28, 2023 | BJDX | $880 | Purchase | 2,000 | $0.44 | Discretionary |
| Mar 27, 2023 | BJDX | $3.5K | Award | 8,000 | $0.44 | Discretionary |
| Mar 27, 2023 | BJDX | $3.5K | Purchase | 8,000 | $0.44 | Discretionary |
| Feb 1, 2023 | BJDX | $24.5K | Payment | 55,612 | $0.44 | Discretionary |
| Feb 1, 2023 | BJDX | $70.0K | Award | 159,090 | $0.44 | Discretionary |